Novo Nordisk | Betriebsaufwand



Operating Expenses Veränderung Datum
ANI Pharmaceuticals USD 194.95M 211M 2024-12
Aurora Cannabis CAD 51.98M 31.53M 2024-12
Bausch Health Companies USD 2.19B 212M 2024-09
Bristol-Myers Squibb USD 11.55B 1.84B 2024-12
Canopy Growth CAD 98.58M 10.03M 2024-12
Corcept Therapeutics USD 156.63M 20.68M 2024-12
Drreddys Laboratories INR 64.87B 2.26B 2024-12
Eli Lilly USD 8.38B 1.53B 2024-12
GlaxoSmithKline GBP 7.42B 402M 2024-12
Merck USD 11.33B 1.4B 2024-12
Novartis USD 11.28B 1.73B 2024-12
Novo Nordisk 37.49B 4.64B 2024-09
Novo Nordisk DKK 37.49B 4.64B 2024-09
Pacira USD 162.55M 145.55M 2024-12
Perrigo USD 1.03B 13.4M 2024-12
Prestige Brands USD 198.36M 1.09M 2024-12
Sanofi EUR 10.07B 969M 2024-09
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
Zoetis USD 1.59B 71M 2024-12



Novo Nordisk Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.